CorMedix Inc.

07/02/2026 | Press release | Distributed by Public on 07/02/2026 14:32

Material Event (Form 8-K)

Item 8.01 Other Events.
On June 29, 2026, CorMedix Inc. (the "Company") effected a change in its executive leadership structure, whereby the Company's Board of Directors has appointed Elizabeth Hurlburt, currently the Chief Operating Officer, to the newly created role of Chief Operating and Commercial Officer where she will have functional oversight of all commercial functions in addition to medical affairs, regulatory and clinical. Ms. Hurlburt will continue to report to Chairman & CEO Joseph Todisco in this newly created role. As part of this change in executive leadership structure, Michael Seckler has left the Company.
CorMedix Inc. published this content on July 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 02, 2026 at 20:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]